| Similar Articles |
|---|
 |
The Motley Fool
September 12, 2010
Anand Chokkavelu |
How Expensive Is Google Stock Right Now? Let's use some carefully chosen metrics to size up Google's true value.   |
The Motley Fool
September 11, 2010
Anand Chokkavelu |
How Much of a Bargain Is Apple Stock Right Now? What can price multiples, consistency of past earnings, and amount of growth expected tell us about Apple's true value? |
The Motley Fool
October 18, 2010
Anand Chokkavelu |
There Are Better Opportunities Than Boston Scientific Let's take a look. By the numbers, Abbott, Medtronic, and Johnson & Johnson all look more compelling than Boston Scientific. |
The Motley Fool
September 3, 2010
Anand Chokkavelu |
Is Microsoft Stock Cheap Right Now? Let's take a look. |
The Motley Fool
September 11, 2010
Anand Chokkavelu |
How Expensive Is Amazon.com Stock Right Now? Let's see what numbers can tell us about how cheap Amazon.com might be. |
The Motley Fool
September 10, 2010
Anand Chokkavelu |
How Expensive Is Abbott Laboratories Stock Right Now? Abbott Laboratories has a mixed performance in hitting the ideal targets, but let's see how it compares against some competitors and industry mates. |
The Motley Fool
September 10, 2010
Anand Chokkavelu |
How Cheap Is IBM Stock Right Now? Let's take a look at how cheaply shares of IBM are trading, how consistent its performance has been, and what kind of growth profile it has -- both on an absolute and a relative basis. |
The Motley Fool
September 10, 2010
Anand Chokkavelu |
How Much of a Bargain Is Home Depot Stock Right Now? Let's take a look. |
The Motley Fool
September 16, 2010
Anand Chokkavelu |
How Cheap Is Brocade by the Numbers? Brocade is 0 for 4 on hitting the ideal targets, but let's see how it compares against some competitors and industry mates. |
The Motley Fool
January 8, 2012
Anand Chokkavelu |
Best Buy's Stock Looks Cheap by the Numbers Let's take a look. |
The Motley Fool
August 13, 2011
Anand Chokkavelu |
RadioShack's Stock Is Cheap Look at what the numbers can tell us about how expensive or cheap RadioShack might be. |
The Motley Fool
August 30, 2010
Anand Chokkavelu |
How Cheap Is ExxonMobil Stock Right Now? Let's take a look. |
The Motley Fool
September 2, 2010
Anand Chokkavelu |
Is Pfizer Stock Cheap Right Now? If you find Pfizer's numbers compelling, continue your due diligence. |
The Motley Fool
September 7, 2010
Anand Chokkavelu |
How Much of a Bargain Is Frontier Communications Right Now? Let's take a look. |
The Motley Fool
September 2, 2010
Anand Chokkavelu |
How Cheap Is General Electric Stock Right Now? Let's use some carefully chosen metrics to size up General Electric's true value. |
The Motley Fool
January 5, 2012
Anand Chokkavelu |
Can Varian's Stock Be Cheap by the Numbers? Let's take a look. |
The Motley Fool
September 17, 2010
Anand Chokkavelu |
How Cheap Is Frontline Stock by the Numbers? Let's see what those numbers can tell us about how cheap oil shipper Frontline might be. |
The Motley Fool
January 17, 2012
Anand Chokkavelu |
Are Covanta's Numbers Worth Looking Into? Covanta has a mixed performance in hitting the ideal targets, but let's see how it compares against some competitors and industry mates. |
The Motley Fool
January 16, 2012
Anand Chokkavelu |
Hidden Cheapness in IAC's Numbers? Let's take a look. |
The Motley Fool
September 2, 2010
Anand Chokkavelu |
Is DuPont Stock Cheap Right Now? Here's how DuPont compares it its peers for trailing five-year growth. |
The Motley Fool
September 17, 2010
Anand Chokkavelu |
How Expensive Is Cirrus Logic Stock by the Numbers? Let's see what the numbers can tell us about how cheap integrated circuit maker Cirrus Logic might be. |
The Motley Fool
October 18, 2010
Anand Chokkavelu |
Seagate Technology Looks Very Cheap by the Numbers Let's take a look. |
The Motley Fool
November 28, 2011
Anand Chokkavelu |
How Reasonable Is Republic Services' Stock by the Numbers? Over the last five years, Republic Services has tallied up five years of positive earnings and five years of positive free cash flow. |
The Motley Fool
September 15, 2010
Anand Chokkavelu |
How Much of a Bargain Is SandRidge Energy Stock Right Now? Let's take a look. |
The Motley Fool
September 2, 2010
Anand Chokkavelu |
How Much of a Bargain Is Schlumberger Stock Right Now? Over the past five years, Schlumberger has tallied up 5 years of positive earnings and 5 years of positive free cash flow. |
The Motley Fool
January 20, 2012
Anand Chokkavelu |
A Look at AES' Initial Numbers Let's take a look. |
The Motley Fool
January 11, 2012
Anand Chokkavelu |
How Pricey Is Goldcorp's Stock by the Numbers? Past growth has been good, but future growth will depend not only on the effectiveness of Goldcorp's spend but also on the price of commodities. |
The Motley Fool
January 19, 2012
Anand Chokkavelu |
Winnebago's Stock by the Numbers Winnebago wisely keeps a debt-free balance sheet that helps it weather the storms. |
The Motley Fool
September 17, 2010
Anand Chokkavelu |
How Much of a Bargain Is Otter Tail by the Numbers? Let's see what those numbers can tell us about how cheap electric utility and diversified manufacturer Otter Tail might be. |
The Motley Fool
September 14, 2010
Anand Chokkavelu |
How Much of A Bargain Is Kinder Morgan Energy Stock Right Now? Let's take a look. |
The Motley Fool
August 24, 2011
Andrew Tonner |
Does Bristol-Myers Squibb Look Like a Winning Investment? Bristol-Myers, Pfizer, and J&J all look tempting, trading in the mid-teens relative to their earnings. |
The Motley Fool
May 13, 2011
Andrew Tonner |
Does Kimberly-Clark Deserve a Spot in Your Portfolio? Let's take a look at Kimberly-Clark and some of its closest peers. |
The Motley Fool
August 28, 2010
Todd Wenning |
Dividend Report Card: Johnson & Johnson Does this health-care titan's dividend pass the test? |
The Motley Fool
October 30, 2010
Anand Chokkavelu |
7 Pharma Stocks Near 52-Week Highs Here are the top seven companies in the pharmaceutical space (by market cap) that are within spitting distance of their 52-week highs: J&J... Novartis... Merck... GlaxoSmithKline... Abbott... AstraZeneca... Novo Nordisk... |
The Motley Fool
August 24, 2011
Andrew Tonner |
Does Abbott Laboratories Look Like a Winning Investment? A quick check of their numbers shows us that Abbott Labs looks reasonably attractive. |
The Motley Fool
April 29, 2011
Andrew Tonner |
Does Intel Deserve a Spot in Your Portfolio? A quick check of its numbers should help get us started. |
The Motley Fool
January 28, 2011
Anand Chokkavelu |
10 Core Stocks: A Johnson & Johnson Update The steady reliability of J&J stock will comfort the core of your portfolio when the market gets a boo-boo. |
The Motley Fool
July 26, 2005
Rich Smith |
J&J: One Pricey Stock This giant of the health-care world reported its second quarter 2005 earnings last week but, by all appearances, failed to impress Wall Street. Johnson & Johnson's become very big, very pricey. |
The Motley Fool
August 18, 2011
Matt Koppenheffer |
3 Companies to Worry About, 3 That Are Safe Just because a company is very profitable right now doesn't mean that it will maintain that same profitability in the years ahead. Take a look at these examples. |
The Motley Fool
July 12, 2011
Todd Wenning |
What Does Johnson & Johnson Do With Its Free Cash? Johnson & Johnson appears to be making fair use of its free cash flow, and its well-covered dividend may be attractive to income-focused investors. |
The Motley Fool
April 30, 2011
Andrew Tonner |
Does IBM Deserve a Spot in Your Portfolio? A quick check of its numbers should help get us started. |
The Motley Fool
May 17, 2011
Andrew Tonner |
Does ConocoPhillips Deserve a Spot in Your Portfolio? A quick check of their numbers should help get us started. |
The Motley Fool
January 23, 2008
Brian Orelli |
A Dose of Stability From J&J Top-line growth looked great at Johnson & Johnson -- more than 16% year over year -- but when you dove a little further into the earnings, growth wasn't quite that stellar. |
The Motley Fool
August 24, 2010
Matt Koppenheffer |
How Much Is Johnson & Johnson Worth? Is Johnson & Johnson's stock on sale? |
The Motley Fool
September 24, 2010
Anand Chokkavelu |
10 Core Stocks for Your Portfolio: Johnson & Johnson The health care behemoth makes the list |
The Motley Fool
December 31, 2007
Brian Orelli |
Best Stock for 2008: Johnson & Johnson Down on its luck for 2007, here's why Johnson & Johnson's stock will rebound in 2008. |
The Motley Fool
June 28, 2011
Eric Bleeker |
Johnson & Johnson Is Looking Abroad for Growth Where's Johnson & Johnson generating its sales? |
The Motley Fool
June 16, 2004 |
Understanding "Multiples" Understanding multiples can help you evaluate a stock's attractiveness. |
The Motley Fool
January 18, 2011
Russ Krull |
Keep It or Sweep It: Johnson & Johnson? Should the company be held or sold? |
The Motley Fool
May 23, 2011
Andrew Tonner |
Does Monsanto Deserve a Spot in Your Portfolio? A quick check of their numbers should help us to find out. |
